{"id":"202","presentation":"304 - The Effect of Renin-Angiotensin-Aldosterone System Inhibition on Morbidity and Mortality during Long-Term Continuous-Flow Left Ventricular Assist Device Support","session":"SESSION 77 - ORAL: Optimal Drug Therapy and Monitoring of MCS Patients","filename":"Brinkley RAAS ISHLT 2020 compressed.pptx","speaker":"M. Brinkley<small>, Nashville, TN, United States of America<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt40th\/202\/jpg\/brinkleyraasishlt2020compressed\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E6671\/session_token\/bbe7c59b4b9d17483db55b51a80f77ef","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]